Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study-Reference-Cited by-同舟云学术

Risk of meningioma among users of high doses of cyproterone acetate as compared with the general population: evidence from a population-based cohort study

Published:2011-11-09 Issue:6 Volume:72 Page:965-968
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

Gil Miguel,Oliva Belén,Timoner Julia,Maciá Miguel A.,Bryant Verónica,de Abajo Francisco J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.2011.04031.x/fullpdf

Reference5 articles.

1. Meningioma;Marosi;Crit Rev Oncol Hematol,2008

2. Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997;Klaeboe;Int J Cancer,2005

3. Froelich S Dali-Youcef N Boyer P Kehrli P Maitrot D Auwerx J Schlienger JL Endocrine abstracts (Proceedings of the 10th European Congress of Endocrinology; Berlin, Germany) 2008 http://www.endocrine-abstracts.org/ea/0016/ea0016p158.htm

4. Pharmacovigilance Working Party (PhVWP) Monthly report, November 2009 http://www.emea.europa.eu/docs/en_GB/document_library/Report/2009/12/WC500016972.pdf

5. El Proyecto BIFAP: base de datos para la Investigación;Salvador Rosa;Aten Primaria,2002

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date review;BMJ Oncology;2024-05

2. Evaluation of selective-serotonin reuptake inhibitors and anti-androgens to manage sexual compulsivity in individuals serving a custodial sentence for a sexual offence;The Journal of Forensic Psychiatry & Psychology;2024-04-16

3. Effects of gender affirming hormone treatment in transgender individuals – a retrospective cohort study;Endocrine;2024-02-22

4. How low can you go? Titrating the lowest effective dose of cyproterone acetate for transgender and gender diverse people who request feminizing hormones;International Journal of Transgender Health;2024-02-20

5. Physician Awareness of the Safe Use of Cyproterone Acetate in Europe: A Survey on the Effectiveness of Additional Risk Minimization Measures;Pharmaceutical Medicine;2024-01-31